Prognostic value of PDL1 expression in pancreatic cancer

Pancreatic cancer is one of the most aggressive human cancers. PD1/PDL1-inhibitors recently showed promising results in different cancers with correlation between PDL1 tumor expression and responses. Expression of programmed cell death receptor ligand 1 (PDL1) has been scarcely studied in pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Birnbaum, David J., Finetti, Pascal, Lopresti, Alexia, Gilabert, Marine, Poizat, Flora, Turrini, Olivier, Raoul, Jean-Luc, Delpero, Jean-Robert, Moutardier, Vincent, Birnbaum, Daniel, Mamessier, Emilie, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342072/
https://www.ncbi.nlm.nih.gov/pubmed/27589570
http://dx.doi.org/10.18632/oncotarget.11685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342072/
https://www.ncbi.nlm.nih.gov/pubmed/27589570
http://dx.doi.org/10.18632/oncotarget.11685

Ejemplares similares